Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Cedars Sinai

C. Ha

ESMO 2024 Summary: Treatment Strategies and Sequencing in Carcinoid …

2024 ESMO Annual Meeting Insights Hub

R. Riechelmann

Hormone Control and Management of Functional NET Syndromes

North American Neuroendocrine Tumor Society

H. Assi

Practice Changing Topics - How the Experts Treat With Dr. Chandler P…

Practice Changing Topics - How the Experts Treat

C. Park, A. Chauhan

Top Ten Advances in IBD 2023

Northwestern Medicine Gastroenterology

S. Hanauer

ACAAI 2024 Insights: The Bench to Bedside Pathway to Bring a Biologi…

ACAAI 2024 Insights

T. B. Casale

Positioning Medical Therapy in IBD

Washington University in St. Louis

M. Ciorba

SWOG S2012: 1L Chemo +/- Atezolizumab in Advanced Extrapulmonary Neu…

Fred Hutchinson Cancer Center

D. Zhen

DDW 2023 Updates and Perspectives: Evolution in Medical Treatments f…

DDW 2023 Conference Coverage

S. Hanauer

Update of Anti-TNF Therapy in Crohn's Disease

Columbia University

G. Lichtenstein

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed

New and Emerging Therapies for Inflammatory Bowel Disease

University of Colorado Department of Medicine

W. Ahmed

How I Optimize Biologic Therapies in IBD

Providence Swedish

T. L. Zisman

Leukocyte Trafficking Agents in the Management of IBD

Washington University in St. Louis

K. Huff-Hardy

Rethinking Current and Future Treatment Sequence of Moderate to Seve…

Columbia University

E. Scherl

Starting IBD Patients on Biologic Therapy: How Long to Wait Before D…

Neeraj Narula

Update of Anti-Integrin Therapy in IBD

Columbia University

B. Sands

Medical Therapy in IBD: Past, Present, and Future

David Choi

Hot Off the Press: What Are We Currently Using? Novel Approved IBD T…

Cedars Sinai

R. Ungaro

Update of Oral Small Molecules in IBD

Columbia University

U. Navaneethan